Answers are grounded in this paper and cite their sources.
Despite showing a wide application in tumor therapy, the clinically‐used exogenous thermal ablation still suffers from uncontrollable temperature field with rapid heat diffusion. Here an endogenous trigger‐encouraged thermal ablation, namely exothermic reaction‐based thermal ablation (ERTA) based on quicklime slaking and acid‐base neutralization reactions, has been established, wherein CaO nanoparticles were encapsulated with Ag nanoparticles by liposomes to construct ERTA ablators. CaO consumes H 2 O and H + after exothermic reactions to give birth to Ca 2+ and heat. Liposome shell prolongs ERTA via limiting the exothermic reaction rate, and intracellular Ca 2+ overload unites with Ag nanoparticles to produce antitumor ROS to boost cancer ERTA. Importantly, polidocanol‐based foam sclerosing agent (PFSA) with low heat conductivity was integrated to inhibit heat diffusion and confine heat in tumor to elevate temperature and enhance ERTA efficiency. Additionally, PFSA as a routine clinical embolism agent destroys intratumoral blood vessels to occlude blood vessels and establish starvation therapy, which further improves PFSA‐enhanced ERTA efficiency. Consequently, such ERTA‐based ablators and PFSA‐integrated ones outperform the scale‐matched microwave ablation and laboratory‐in photothermal ablation in repressing subcutaneous and orthotopic hepatocellular carcinoma, and orthotopic pancreatic cancer. This endogenous trigger‐activated thermal ablation method provides distinctive insights into thermal ablation, presenting a new thermal ablation protocol.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: